Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy

Author： Kemp Kevin Morse Ruth Wexler Sarah Cox Christine Mallam Elizabeth Hows Jill Donaldson Craig

ISSN： 0939-5555

Source： Annals of Hematology, Vol.89, Iss.7, 2010-07, pp. : 701-713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Relation Between Hematological Recovery and Number of Transplanted Mononuclear Cells in Patients after High Dose Chemotherapy with Peripheral Blood Stem Cell (PBSC) Rescue

By Koumakis G. Filis J. Vassilomanolakis M. Papanastasiou K. Hajichristou H. Barbounis V. Stamatellou M. Efremidis A.P.

Blood Cells, Molecules, and Diseases, Vol. 21, Iss. 3, 1995-12 ,pp. : 235-238

Academic Press

Access to resources Recommend Favorite

Recent thymic output function in patients with hematological malignancy

By Li Yangqiu

Hematology, Vol. 10, Iss. 4, 2005-08 ,pp. : 297-305

Maney Publishing

Access to resources Recommend Favorite

Autologous stem cell transplantation in hematological malignancies

By Gorin Norbert-Claude

Springer Seminars in Immunopathology, Vol. 26, Iss. 1-2, 2004-11 ,pp. : 3-30

Springer Publishing Company

Access to resources Recommend Favorite

Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells

Current Stem Cell Research & Therapy, Vol. 11, Iss. 2, 2016-02 ,pp. : 122-130

Bentham Science Publishers

Access to resources Recommend Favorite

Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.

Current Stem Cell Research & Therapy, Vol. 11, Iss. 2, 2016-02 ,pp. : 141-148

Bentham Science Publishers

Access to resources Recommend Favorite